Daniel Herranz
Has grant
Assistant Professor of Pharmacology
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Daniel Herranz is an Assistant Professor of Pharmacology at Rutgers Cancer Institute of New Jersey. His research primarily focuses on T-cell leukemia, including the mechanisms of high-risk T-lineage acute lymphoblastic leukemia and potential therapeutic targets within the NOTCH1 signaling pathway. Recent publications highlight his work on mitochondrial metabolism in leukemia and the role of the spleen in T-cell malignancies, indicating a strong commitment to advancing treatment strategies in hematological cancers.
Recent Grants
Grant: Open
Therapeutic exploitation of novel mouse models and metabolic interventions in leukemia
Open Date: 2022-07-01
Close Date: 2027-06-01
Grant: Close
Dissecting the antileukemic potential of a novel antibiotic drug
Open Date: 2021-01-01
Close Date: 2022-01-01
Grant: Close
The role of SIRT1 in T-Cell Acute Lymphoblastic Leukemia
Open Date: 2020-01-01
Close Date: 2024-12-01
Grant: Close
Novel metabolic and epigenetic therapies in T-ALL
Open Date: 2019-12-01
Close Date: 2020-12-01
Grant: Close
The role of glutaminolysis as a therapeutic target in T-ALL
Open Date: 2019-07-01
Close Date: 2024-06-01
Articles (9)
Year:
2025
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (8)
anne tierens
University Health Network
Ken Furudate
The University of Texas MD Anderson Cancer Center
Tom Taghon
Professor at Ghent University
Ghent University
Gregory Ducker
Assistant Professor
University of Utah
Katarzyna Tomczak
The University of Texas MD Anderson Cancer Center
Trang Hoang
Principal Investigator and Professor
-
Camille Lobry
-
Victoria da Silva-Diz
Rutgers Cancer Institute of New Jersey
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.